Stable Istotope Labelled Gontivimab Biosimilar – Anti-RSV glycoprotein F mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Stable Istotope Labelled Gontivimab Biosimilar - Anti-RSV glycoprotein F mAb - Research Grade |
|---|---|
| Source | Drugbank DB16179 |
| Species | Lama glama |
| Expression system | Mammalian cells |
| Purity | >95% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue Ice |
| Delivery Time | 3-5 days if in stock; 5-8 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | ALX-0171,VR-465 |
| Reference | PX-TA1405-SIL |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | VH-VH-VH |
| Clonality | Monoclonal Antibody |
| Format | Lyophilized |
| Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2, >99% |
| Isotopic Enrichment | 99% |
| Stability | 1 year |
General information on Anti-RSV glycoprotein F[Respiratory syncytial virus] (Gontivimab ) Monoclonal Antibody
Gontivimab is investigated for the treatment and prevention of Respiratory Syncytial Virus (RSV) Infection.
Contact us
Send us a message from the form below
Reviews
There are no reviews yet.